69492 Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices 

II. Town Hall Meeting and Conference 

Calling/Live Streaming Information 

A. Format of the Town Hall Meeting 

As noted in section I. of this notice, 

we are required to provide for a meeting 

at which organizations representing 

hospitals, physicians, manufacturers 

and any other interested party may 

present comments, recommendations, 

and data to the clinical staff of CMS 

concerning whether the service or 

technology represents a substantial 

clinical improvement. This meeting will 

allow for a discussion of the substantial 

clinical improvement criteria for each of 

the FY 2016 new medical services and 

technology add-on payment 

applications. Information regarding the 

applications can be found on our Web 

site at http://www.cms.gov/Medicare/

Medicare-Fee-for-Service-Payment/

AcuteInpatientPPS/newtech.html. 

The majority of the meeting will be 

reserved for presentations of comments, 

recommendations, and data from 

registered presenters. The time for each 

presenter’s comments will be 

approximately 10 to 15 minutes and 

will be based on the number of 

registered presenters. Presenters will be 

scheduled to speak in the order in 

which they register and grouped by new 

technology applicant. Therefore, 

individuals who would like to present 

must register and submit their agenda 

item(s) via email to newtech@

cms.hhs.gov by the date specified in the 

DATES section of this notice. 

In addition, written comments will 

also be accepted and presented at the 

meeting if they are received via email to 

newtech@cms.hhs.gov by the date 

specified in the DATES section of this 

notice. Written comments may also be 

submitted after the meeting for our 

consideration. If the comments are to be 

considered before the publication of the 

proposed rule, the comments must be 

received via email to newtech@

cms.hhs.gov by the date specified in the 

DATES section of this notice. 

B. Conference Call, Live Streaming, and 

Webinar Information 

For participants who cannot attend 

the Town Hall Meeting in person, an 

open toll-free phone line, (877) 267– 

1577, has been made available. The 

Meeting Place meeting ID is 993 601 

192. 

Also, there will be an option to view 

and participate in the Town Hall 

Meeting via live streaming technology 

and/or a webinar. Information on the 

option to participate via live streaming 

technology and/or a webinar will be 

provided through an upcoming listserv 

notice and posted on the New 

Technology Web site at http://

www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/

AcuteInpatientPPS/newtech.html. 

Continue to check the Web site for 

updates. 

Disclaimer: We cannot guarantee the 

reliability of live streaming technology 

and/or a webinar. 

III. Registration Instructions 

The Division of Acute Care in CMS is 

coordinating the meeting registration for 

the Town Hall Meeting for the FY 2016 

Applications for New Medical Services 

and Technology Add-On Payments on 

substantial clinical improvement. While 

there is no registration fee, individuals 

planning to attend the Town Hall 

Meeting in person must register to 

attend. 

Registration may be completed online at the following web address: 

http://www.cms.gov/Medicare/

Medicare-Fee-for-Service-Payment/

AcuteInpatientPPS/newtech.html. 

Select the link at the bottom of the page 

‘‘Register to Attend the New Technology 

Town Hall Meeting’’. After completing 

the registration, on-line registrants 

should print the confirmation page(s) 

and bring it with them to the meeting(s). 

If you are unable to register on-line, 

you may register by sending an email to 

newtech@cms.hhs.gov. Please include 

your name, address, telephone number, 

email address, and fax number. If 

seating capacity has been reached, you 

will be notified that the meeting has 

reached capacity. 

IV. Security, Building, and Parking 

Guidelines 

Because this meeting will be located 

on Federal property, for security 

reasons, any persons wishing to attend 

this meeting must register by the date 

specified in the DATES section of this 

notice. Please allow sufficient time to go 

through the security checkpoints. It is 

suggested that you arrive at 7500 

Security Boulevard no later than 8:30 

a.m. e.s.t. 

Security measures include the 

following: 

• Presentation of government-issued 

photographic identification to the 

Federal Protective Service or Guard 

Service personnel. 

• Interior and exterior inspection of 

vehicles (this includes engine and trunk 

inspection) at the entrance to the 

grounds. Parking permits and 

instructions will be issued after the 

vehicle inspection. 

• Passing through a metal detector 

and inspection of items brought into the 

building. We note that all items brought 

to CMS, whether personal or for the 

purpose of demonstration or to support 

a demonstration, are subject to 

inspection. We cannot assume 

responsibility for coordinating the 

receipt, transfer, transport, storage, setup, safety, or timely arrival of any 

personal belongings or items used for 

demonstration or to support a 

demonstration. 

Note: Individuals who are not registered in 

advance will not be permitted to enter the 

building and will be unable to attend the 

meeting in person. The public may not enter 

the building earlier than 45 minutes prior to 

the convening of the meeting(s). 

All visitors must be escorted in areas 

other than the lower and first floor 

levels in the Central Building. Seating 

capacity is limited to the first 250 

registrants. 

Authority: Section 503 of Pub. L. 108–173. 

Dated: October 28, 2014. 

Marilyn Tavenner, 

Administrator, Centers for Medicare & 

Medicaid Services. 

[FR Doc. 2014–27579 Filed 11–20–14; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Generic Clearance for the 

Collection of Qualitative Feedback on 

Agency Service Delivery. 

OMB No.: 0970–0401. 

Description: Executive Order 12862 

directs Federal agencies to provide 

service to the public that matches or 

exceeds the best service available in the 

private sector. In order to work 

continuously to ensure that the 

Administration for Children and 

Families’ programs are effective and 

meet our customers’ needs we use a 

generic clearance process to collect 

qualitative feedback on our service 

delivery. This collection of information 

is necessary to enable ACF to garner 

customer and stakeholder feedback in 

an efficient timely manner, in accord 

with our commitment to improving 

service delivery. The information 

collected from our customers and 

stakeholders will help ensure that users 

have an effective, efficient and 

satisfying experience with the programs. 

This feedback will provide insights into 

customer or stakeholder perceptions, 

experiences and expectations, provide 

an early warning of issues with service, 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices 69493 

or focus attention on areas where 

communication, training or change in 

operation might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative and 

actionable communications between 

ACF and its customer and stakeholders. 

It will also allow feedback to contribute 

directly to the improvement of program 

management. 

This request is an extension of the 

‘‘generic fast-track’’ process offered to 

all government agencies by OMB in 

2010. Fast-track means each request 

receives approval five days after 

submission, if no issues are brought to 

ACF’s attention by OMB within the five 

days. 

Respondents 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Survey .............................................................................................................. 5,000 1 0.5 2,500 

Estimated Total Annual Burden 

Hours: 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade SW., Washington, DC 20447, 

Attn: ACF Reports Clearance Officer. 

Email address: infocollection@

acf.hhs.gov. All requests should be 

identified by the title of the information 

collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2014–27558 Filed 11–20–14; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0510] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Substances 

Prohibited From Use in Animal Food or 

Feed 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the recordkeeping requirements for 

substances prohibited for use in animal 

food or feed. 

DATES: Submit electronic or written 

comments on the collection of 

information by January 20, 2015. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http://

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd., COLE–14526, Silver 

Spring, MD 20993–0002, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

Agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined 

in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes Agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA (44 

U.S.C. 3506(c)(2)(A)) requires Federal 

Agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each proposed extension of an 

existing collection of information, 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, FDA is publishing notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, FDA invites 

comments on these topics: (1) Whether 

the proposed collection of information 

is necessary for the proper performance 

of FDA’s functions, including whether 

the information will have practical 

utility; (2) the accuracy of FDA’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques, 

when appropriate, and other forms of 

information technology. 

mstockstill on DSK4VPTVN1PROD with NOTICES